Dr. David Pai, MD

NPI: 1023190808
Total Payments
$37,989
2024 Payments
$571.02
Companies
15
Transactions
101
Medicare Patients
2,298
Medicare Billing
$971,307

Payment Breakdown by Category

Other$24,143 (63.6%)
Travel$6,203 (16.3%)
Food & Beverage$3,827 (10.1%)
Consulting$3,600 (9.5%)
Education$215.49 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,143 11 58.3%
Travel and Lodging $6,203 12 16.3%
Food and Beverage $3,827 68 10.1%
Consulting Fee $3,600 1 9.5%
Honoraria $2,000 1 5.3%
Education $215.49 8 0.6%

Top Paying Companies

Company Total Records Latest Year
Vifor Pharma, Inc. $18,128 20 $0 (2023)
Relypsa, Inc. $16,048 31 $0 (2020)
Fresenius USA Marketing, Inc. $2,132 3 $0 (2023)
Amgen Inc. $305.43 6 $0 (2024)
Mallinckrodt LLC $243.09 2 $0 (2018)
Novartis Pharmaceuticals Corporation $239.59 6 $0 (2024)
Alexion Pharmaceuticals, Inc. $238.29 2 $0 (2024)
Aurinia Pharma U.S., Inc. $195.90 6 $0 (2022)
Travere Therapeutics, Inc. $188.83 6 $0 (2024)
Mallinckrodt Hospital Products Inc. $181.85 13 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $571.02 14 Novartis Pharmaceuticals Corporation ($239.59)
2023 $2,467 10 Fresenius USA Marketing, Inc. ($2,132)
2022 $18,346 27 Vifor Pharma, Inc. ($18,099)
2021 $187.05 14 Mallinckrodt Hospital Products Inc. ($146.96)
2020 $22.35 1 Relypsa, Inc. ($22.35)
2019 $209.88 2 Relypsa, Inc. ($209.88)
2018 $9,573 17 Relypsa, Inc. ($9,214)
2017 $6,612 16 Relypsa, Inc. ($6,602)

All Payment Transactions

101 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/10/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $19.63 General
Category: Immunology
10/16/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $100.97 General
Category: Immunology
10/10/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $31.43 General
Category: Immunology
09/13/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $13.85 General
Category: GASTROENTEROLOGY
08/08/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $33.64 General
08/06/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $14.85 General
Category: Inflammation/Rare Disease
07/25/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $25.77 General
07/23/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $13.75 General
05/28/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $28.15 General
05/09/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $113.30 General
05/03/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $15.98 General
03/09/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $112.59 General
Category: Inflammation
03/01/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $17.25 General
Category: GASTROENTEROLOGY
02/05/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $29.86 General
Category: Inflammation
12/14/2023 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $149.86 General
10/24/2023 Travere Therapeutics, Inc. Education In-kind items and services $3.08 General
10/24/2023 Travere Therapeutics, Inc. Education In-kind items and services $3.08 General
10/24/2023 Travere Therapeutics, Inc. Education In-kind items and services $3.08 General
07/17/2023 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $21.29 General
Category: Phosphate binder for ESRD
07/05/2023 Fresenius USA Marketing, Inc. KORSUVA (Drug) Honoraria Cash or cash equivalent $2,000.00 General
Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP
06/22/2023 Fresenius USA Marketing, Inc. KORSUVA (Drug) Food and Beverage Cash or cash equivalent $111.12 General
Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP
06/14/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $124.99 General
03/04/2023 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $28.78 General
Category: Hyperkalemia
02/10/2023 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $21.63 General
Category: Inflammation
11/28/2022 Vifor Pharma, Inc. Korsuva (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,090.00 General
Category: CKD-aP

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 464 1,217 $410,635 $183,814
2022 8 541 1,455 $532,348 $237,004
2021 8 589 1,638 $603,695 $283,801
2020 10 704 1,865 $686,695 $266,688
Total Patients
2,298
Total Services
6,175
Medicare Billing
$971,307
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 74 536 $268,000 $129,321 48.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 105 280 $42,280 $18,233 43.1%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2023 45 99 $38,412 $16,664 43.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 129 170 $26,690 $8,073 30.2%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 14 19 $11,286 $5,616 49.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 57 73 $16,790 $3,448 20.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 11 11 $3,113 $1,188 38.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 16 16 $3,648 $1,172 32.1%
99421 Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes Office 2023 13 13 $416.00 $100.24 24.1%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 108 762 $381,000 $185,236 48.6%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2022 71 144 $55,984 $23,633 42.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 165 247 $38,779 $10,599 27.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 70 152 $22,952 $8,438 36.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 63 82 $18,860 $4,002 21.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 18 19 $5,377 $2,036 37.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 25 25 $5,700 $1,730 30.3%
90935 Hemodialysis procedure with physician evaluation Facility 2022 21 24 $3,696 $1,331 36.0%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 117 845 $422,500 $207,630 49.1%
90962 Dialysis services (1 physician visit per month), patient 20 years of age and older Office 2021 82 196 $76,048 $33,516 44.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 170 267 $41,919 $16,972 40.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 86 122 $28,060 $12,600 44.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 79 148 $22,348 $8,740 39.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 18 18 $5,094 $1,816 35.7%
90935 Hemodialysis procedure with one physician evaluation Facility 2021 20 25 $3,850 $1,466 38.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 17 17 $3,876 $1,060 27.4%

About Dr. David Pai, MD

Dr. David Pai, MD is a Specialist healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023190808.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pai, MD has received a total of $37,989 in payments from pharmaceutical and medical device companies, with $571.02 received in 2024. These payments were reported across 101 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,143).

As a Medicare-enrolled provider, Pai has provided services to 2,298 Medicare beneficiaries, totaling 6,175 services with total Medicare billing of $971,307. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Location Sacramento, CA
  • Active Since 10/20/2006
  • Last Updated 03/07/2012
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1023190808

Products in Payments

  • Veltassa (Drug) $16,178
  • Korsuva (Drug) $2,791
  • KORSUVA (Drug) $2,111
  • ACTHAR (Biological) $424.94
  • LUPKYNIS (Drug) $195.90
  • TAVNEOS (Drug) $164.08
  • Fabhalta (Drug) $152.03
  • Parsabiv (Biological) $103.50
  • IBSRELA (Drug) $31.10
  • Tavneos (Drug) $23.00
  • Velphoro (Drug) $21.29
  • LOKELMA (Drug) $20.35
  • KRYSTEXXA (Biological) $14.85
  • BENLYSTA (Biological) $12.88
  • JYNARQUE (Drug) $12.51
  • Uloric (Drug) $10.35

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Sacramento